Sentinels / Actor desk
Novartis
organization · Registry status: unverified
77b424f0-a1ec-5b4c-b519-0a0d891335a2
Evidence, not intent.
Public-source event mentions and stored signals. Adjacency does not establish causation, coordination, or an actor's position.
No claim of complete coverage or live monitoring.
Observation window
UTC dates, inclusive · maximum 90 days. Applies to events and anomalies only.
Recent observations / timeline
The source record
200 distinct events shown, newest first. More matches exist; narrow the dates to inspect beyond the latest 200. Headlines may be generated summaries; inspect the source before repeating a claim.
swissinfo.ch: Matthew Allen, Jessica Davis Pluess, Kerstin Vokinger (tax ethnicity german, tax worldlanguages german)
BlackRock Greater Europe Investment Trust Plc - Final Results
serbiananimalsvoice.com: Melinda Gates, Melinda Gates, Melinda Gates (epu cats healthcare, general government)
The quest for immortality has become serious business
novartis heart drug lp(a) trial failure raises heart health questions
BioArctic Says Novartis Ends Deal With Up to US$772 Million in Potential Milestones | EconoTimes
I Was On A Swiss Public Eye Panel Devoted To Hating Science: Here's Why You Should Be Also
BioArctic collaborator Novartis terminates agreement
Heartfelt Edema Monitor Improves HF Outcomes, May Provide Durable Benefit | HCPLive
Novartis Heart Drug Failure Leaves Doctors Seeking Evidence for Genetic Cholesterol Target
BioArctic collaborator Novartis terminates agreement
Western Pharma Giants Paid Millions to Russian Distributors Linked to Fraud, Whistleblower Report Says - The Moscow Times
Futures Rise As Oil Slides Below $100 On Trump Iran Diplomacy Report, Tech Bounces Ahead Of Midterms
Can a Gene Expression Test Guide Atopic Dermatitis Therapy Selection? | HCPLive
Former Gilead Head of U.S. Medical Affairs Dean Hakanson, MD, Joins GOA Therapeutics as Chief Medical Officer
Futures Rise As Oil Slides Below $100 On Trump Iran Diplomacy Report, Tech Bounces Ahead Of Midterms - ChinaTechNews.com
Reviewing Ionis Pharmaceuticals (NASDAQ:IONS) & Pluri (NASDAQ:PLUR)
The Rise Of Theranostics And The Fight To Accelerate Access
Trump is reportedly favouring diplomacy with Iran; DXY is under mild pressure awaiting midterms - Newsquawk US Market Open
Colon cancer rates rise across age groups
Pharma giants pay millions to Russian distributor entangled in corruption allegations to win cancer drug business - ICIJ
Companies Report AI Gains, but Most Do Not Quantify the Payoff | EconoTimes
Companies promised AI gains— here's how the payoff showed up in earnings
Rise in US colon cancer rates not limited to young adults, analysis finds
'Baywatch' star Nicole Eggert exposes financial toll of cancer battle: 'The bills don't stop'
Anthropic's next big AI business is life sciences, from biotech research to drug discovery
Google spinoff Isomorphic Labs is in a race to shake up the long, painful road to cancer-beating drugs
Need a new, better drug to tackle a serious illness? In Canada, you have to ‘fail’ on an old drug first
49ers TE George Kittle Teams Up With Novartis For Prostate Cancer Awareness
Advances in Cancer Care Are Moving Closer to Home - Shelbyville Times-Gazette
Biologic Selection and Comorbidity Screening in HS, With Jennifer Hsiao, MD | HCPLive
finanzen.ch: Lindt Spruengli, Julius Baer, Logitech International (uspec policy1, epu policy policy)
Q&A: How to avoid missing a case of pediatric malaria
MHRA Approves Icotyde Oral IL-23 Peptide for UK Psoriasis - Pharmaceutical Industry News - Zenopa UK
Earnings roundup: Lilly’s unwavering momentum, Novartis’ rebound and GSK’s waiting game
BTK Inhibitor Reduces MS Relapse Rates in Two Phase 3 Trials
ABCs in Dermatology: Rethinking JAK Inhibitor Safety in Atopic Dermatitis | HCPLive
All the winners: Tribeca and DNA Brand Architects take top honours
Resources of Austrian hospital-based departments of neurology and psychiatry for new amyloid-antibody therapies in early Alzheimer dementia
Artiva halts its autoimmune cell therapy trial after two deaths, including one linked to pre-treatment chemotherapy
Molecular Partners could cut nearly half its workforce while keeping its lead cancer drug trial on track
Multinationals gear up for ninth edition of CIIE
CIIE 2026
Kidney Compass: Testing SGLT2 Inhibition in Rapidly Progressing ADPKD | HCPLive
Swiss Market Ends On Strong Note
Swiss Market Ends On Strong Note
swissinfo.ch: Astrazeneca, Pfizer, Google (wb 1358 generic drugs, legislation)
4 Long-Term Survival Results From ESMO 2026 Patients Should Know | CURE
Should You Buy Royalty Pharma Stock Before Nov. 4? | The Motley Fool
Anupriya Patel shares government's health roadmap at Times Network India Health Summit & Awards 2026
Bristol Myers raises 2026 revenue forecast, lowers EPS due to charge - KSEV Radio 700
indiankanoon.org: Shobrati Khan, Ram Swarath Sinha, Bajaj Allianz (econ unions, wb 1668 labor standards)
T-DXd Plus Pertuzumab Improves Outcomes in HER2+ Breast Cancer With Brain Metastases | OncLive
Cancer drug price cap: Thiotepa gets 91% cut, Keytruda remains at Rs 2.16 lakh [see revised prices]
Why Fundraising Should Be Strategic, Not Reactive
Targeted drug combination extends survival in advanced kidney cancer
Combining 2 VEGF-Blocking Targeted Therapies Significantly Boosted Survival in Kidney Cancer Study | Newswise
MCADDI 2026 brings global drug discovery expertise to India
MARKETS LIVE: Wall Street rebounds as Anthropic IPO filing revives AI trade
Vicks overtakes Skyrizi in September pharma TV rankings as Tums tops YouTube
Trading Day: AI light, Brazil flight - AOL
Sac-TMT Improves PFS and OS, Is Under FDA Priority Review in Previously Treated Endometrial Cancer | OncLive
J&J's potential 'game-changer' drug — plus, what Microsoft's mass buyouts mean
Early ctDNA Clearance Linked to Improved Survival With Pembrolizumab Regimen in HPV-Negative HNSCC | OncLive
Five facts economic developers should know about North Carolina manufacturing
Which Pharmaceutical ETF Is the Better Buy: iShares’ Domestic IHE or VanEck’s Global PPH? | The Motley Fool
SAP Unleashes Autonomous Enterprise with New AI Solutions to Drive Innovation
Futures Rise As Meta Jumps On $95BN Equity Raise, Oil Slides; Brazil Crashes After Lula Shock
Lutikizumab achieves ‘rigorous bar’ for hidradenitis suppurativa response: Topline data
Inflammation, autoimmune diseases common threads in cardiology, dermatology, rheumatology
Which Pharmaceutical ETF Is the Better Buy: iShares’ Domestic IHE or VanEck’s Global PPH? | The Motley Fool
Crude benchmarks move lower which is lifting sentiment across US equity futures; OATs outperform post-Moody's - Newsquawk US Market Open - ChinaTechNews.com
Anthropic's filing for blockbuster US IPO shows key executives and board
Futures Rise As Meta Jumps On $95BN Equity Raise, Oil Slides; Brazil Crashes After Lula Shock
The discovery of new bacteria creates new doors for prostate cancer research - Life Science Industry News - Zenopa UK
UK HealthCare patient among first in US to receive experimental lupus treatment
China cancer patient who inspired hit film hopes to stop treatment after 35,000 pills over two decades
Durvalumab Plus BCG Improves DFS in Papillary-Only, BCG-Naive High-Risk NMIBC in POTOMAC | OncLive
Durvalumab Plus Olaparib Improves Numerical OS in Advanced Endometrial Cancer | OncLive
Kidney Compass: Final 2-Year TELIGAN Data for Telitacicept in IgA Nephropathy | HCPLive
Final postMONARCH OS Favors Abemaciclib Plus Fulvestrant in HR+/HER2–Advanced Breast Cancer | OncLive
T-DXd Followed by THP Elicits Deep MRI Responses in HER2+ Early Breast Cancer | OncLive
Biotech stocks are surging. How investors can play the new drug innovation boom
Black Titan (NASDAQ:BTTC) versus Cycurion (NASDAQ:CYCU) Critical Contrast
Novartis Drug Lowers Annualized Relapse Rates by Up to 35.2% in MS Trials | EconoTimes
Aston University-led international study finds ADHD medication unlikely to raise risk of self-harm
Novartis Reports 19.1% Lower Death Risk in Six-Year Kisqali Analysis | EconoTimes
Roll Call Factba.se - Consolidated White House Releases
Novartis Pharma AG: Novartis remibrutinib delivered comprehensive disease control in Phase III RMS trials, with proven, robust safety profile
finanzen.net: Novartis Rhapsido, European Commission, Novartis (wb 678 digital government, wb 694 broadcast and media)
Novartis's Kisqali Shows Six-Year Survival Benefit In Early Breast Cancer
INESSS recommends reimbursement of KISQALI® for all eligible patients with early-stage breast cancer at high risk of recurrence
Novartis Pharma AG: Kisqali shows clinically meaningful overall survival in broadest HR+/HER2- early breast cancer population at high risk of recurrence
FDA Grants Accelerated Approval to Ravulizumab for Proteinuria Reduction in IgA Nephropathy | Pharmacy Times
Alcon bolsters retina portfolio with $550m Neurotech acquisition
finanzen.ch: Julius Baer, Swisscom, Straumann Holding (wb 698 trade, econ stockmarket)
"India needs more clinician-scientists and engineers who can work across neuroscience, medicine and technology"
Kidney Compass: ORIGIN 3 Final eGFR Data for Atacicept in IgA Nephropathy | HCPLive
swissinfo.ch: Eli Lilly, Thomas Schinecker, Thomas Schinecker (tax fncact chief, epu economy historic)
This 'living drug' could change the course of autoimmune disease
openpr.com: Sanofi Pasteur, Dynavax Technologies Corporation, Pfizer
Domestic Banks Step Up to Fund India Deal Boom
How The NYT Hid Big Pharma PR Titan Jack Leslie In Plain Sight
How The NYT Hid Big Pharma PR Titan Jack Leslie In Plain Sight
Indian banks open cheque books for ₹10,000 crore-plus in M&A funding after RBI rule change
Domestic Banks Step Up to Fund India Deal Boom
bostonglobe.com: Google Deepmind, Ben Wolf, Krishna Yeshwant (wb 2670 jobs, wb 696 public sector management)
Special Report: Remibrutinib, an Oral BTKi, for Chronic Inducible Urticaria | HCPLive
Novartis (NVS) Grew Sales Again as Entresto Fell 50%, Can Remibrutinib Carry It?
Updated hidradenitis suppurativa guidelines recommend multiple biologics, JAK inhibitors
OpenAI vs Google DeepMind: How the AI drug discovery race is shaping up
Where You Live Shouldn't Limit Your Cancer Care - Shelbyville Times-Gazette
Novartis Pharma AG: Novartis receives European Commission approval for Cosentyx in polymyalgia rheumatica (PMR)
Europe’s last penicillin plant faces a bitter fight against China’s cheaper drugs
The medical record’s evolution across generations: What’s next?
Xolair biosimilar Omlyclo commercially available in US
Where You Live Shouldn't Limit Your Cancer Care
swissinfo.ch: Virginie Mangin, Donald Trump, Neil Grubert (science, science)
Frespaciguat Misses 6MWD End Point in PH-COPD: Gabor Kovacs, MD, PhD | HCPLive
HSE could be saving nearly €150m annually by using more biosimilar drugs
Metabolic Dysfunction-Associated Steatohepatitis Clinical Trial and Competitive Landscape Expands as 180+ Companies Target New Treatment Options | DelveInsight
Q&A: Nemolizumab Sustains Itch, Skin Gains in Early Responders at 3 Years | HCPLive
FedEx Europe Launches Portal to Improve Pharma Logistics
Akari Therapeutics Seeks To Address ADC Resistance With Novel PH1 Payload; Stock Up
Obesity Clinical Trial and Competitive Landscape Surges as 200+ Companies Advance Next-Generation Therapies | DelveInsight
Lebrikizumab relieves ‘debilitating’ symptoms of hand, foot dermatitis in phase 3 study
Biotech and Pharma Industry News | BioPharma Dive
Royal Philips: EXIT-CVD research consortium launches clinical studies to transform cardiovascular care across Europe
iOnctura appoints Paul Sekhri as Chair of its Board of Directors
EXIT-CVD research consortium launches clinical studies to transform cardiovascular care across Europe
Biotech and Pharma Industry News | BioPharma Dive
52-Week Litifilimab Data in Cutaneous Lupus Erythematosus | HCPLive
Biotech and Pharma Industry News | BioPharma Dive
100 years: Plant breeder reflects on past, future innovations
marketplace.org: Lori Okeefe, Travis Crayton, Erin Koshut (tax fncact vice president, soc pointsofinterest headquarters)
100 years: Plant breeder reflects on past, future innovations
Swiss Market Closes On Strong Note
Vanda Pharmaceuticals Provides Update on VQW-765 Clinical Development Program
Vanda Pharmaceuticals Provides Update on VQW-765 Clinical Development Program
Swiss Market Closes On Strong Note
Does Long-Term HIV Therapy Cut Anogenital Cancer Risk?
Biotech and Pharma Industry News | BioPharma Dive
Cocaine Use Disorder Market Outlook to Strengthen During the Forecast Period (2026-2036) with Emerging Therapies and Rising Healthcare Needs | DelveInsight
Browns continue fight against cancer with annual “Crucial Catch” game against Baltimore Ravens on Oct. 18
Cocaine Use Disorder Market Outlook to Strengthen During the Forecast Period (2026-2036) with Emerging Therapies and Rising Healthcare Needs | DelveInsight
AI-Designed Biologics Are Moving From the Screen to the Bench, and Developers Are Hiring for the Next Test
Top 10: Pharmaceuticals in EMEA
MindWalk Holdings Corp. Strengthens Boston-Based Development Leadership as Pipeline Advances Toward Preclinical Efficacy Studies
CAS and Novartis collaborate to advance access to reaction data and AI research
MindWalk Holdings Corp. Strengthens Boston-Based Development Leadership as Pipeline Advances Toward Preclinical Efficacy Studies
MindWalk Holdings Corp. Strengthens Boston-Based Development Leadership as Pipeline Advances Toward Preclinical Efficacy Studies
Novartis FY2027 Earnings Forecast Cut by Erste Group Bank
Matchpoint Therapeutics Expands Leadership Team with Appointment of John O’Malley, M.D., Ph.D., as Chief Medical Officer
Nanoscope Therapeutics Appoints Gene Therapy Operations Leader Troy Short as Senior Vice President, Manufacturing and Supply Chain
Head to Head Analysis: Roivant Sciences (NASDAQ:ROIV) vs. Pharming Group (NASDAQ:PHAR)
swissinfo.ch: Olivier Michielin, Nerys Avery, Stefan Schneider (tax disease diseases, tax disease diseases)
Monthly Valuation Update and Factsheet | Company Announcement | Investegate
UK High Court Upholds Novartis’s Sacubitril Valsartan SPC: What Is The Relevant “product”?
Strict liability is gaining traction as an idea for forcing AI companies to get serious about safety | Fortune
King Street Properties Secures $238M Life Sciences Refi From Starwood
ADtouch: Lebrikizumab Eases Itch and Pain in Hand and Foot Eczema | HCPLive
mmv.org: David Fidock, Expert Scientific Advisory Committee, Shin Poong Pharmaceutical Co (wb 2299 pipelines, wb 539 oil and gas policy strategy and institutions)
No New Safety Signals Over 3 Years in HS With Bimekizumab: Amit Garg, MD | HCPLive
Eyes on Asia: TCGX, Biohaven, Roche
Pompe Disease Market Set for Expansion During the Forecast Period (2026-2036) as Growth is Fueled by Next-Generation ERTs, Newborn Screening, and Pipeline Innovation | DelveInsight
Specialty Pharmaceutical Market Size, Share, Growth, Trends and Forecast to 2035
Sibylla Biotech Appoints Usman Azam CEO, Gianluca Fuggetta CFO, and Expands Executive Team to Drive Transition to Clinic
Argenx Stops Phase 3 Vyvgart Trial in Sjögren's Disease After Monitors Find the Study Cannot Meet Its Goal
Independence gains value: Recent radiopharma transactions highlight the strategic value of EUZ's independent ...
Government, KEMSA call for stronger pharmacist leadership to ensure medicine availability
SLNB May Aid Staging in Locally Advanced Breast Cancer
Ionis Pharmaceuticals (NASDAQ:IONS) & Upstream Bio (NASDAQ:UPB) Head to Head Review
Atopic Dermatitis Biologic Selection, With Raj Chovatiya, MD, PhD | HCPLive
When Oncology Gets a Blockbuster | Pharmacy Times
Data on PDE9 inhibition in HF mixed; more research planned
New Guidance for CAR T-Cell Therapy in Autoimmune Disease
Prader-Willi Syndrome Market to Expand by 2036 as New Therapeutic Opportunities Address Unmet Clinical Needs | DelveInsight
REGENXBIO to Host Investor Event Highlighting Surabgene Lomparvovec (Sura-vec) in Wet AMD on October 20
Mint Explainer | How the NPPA plans to rein in cancer drug prices | Mint
Q&A: Comorbidity Screening and Biologic Timing in HS, With Jennifer Hsiao, MD | HCPLive
Atopic Dermatitis Pipeline and Remibrutinib Approval for Dermographism | HCPLive
SAP puts the autonomous enterprise to work - IT-Online
Optogenetics: From Nobel Prize to Commercial Reality. The Science, the Clinic and Who Holds the Pipeline
Henrietta Lacks’ legacy remains a family and institutional conversation 75 years after her death
Novartis AG (NYSE:NVS) Stock Has Consensus Target Price of $145.60
Rhapsido Becomes First FDA-Approved Treatment for Hives Triggered by Scratching, but Fewer Than a Third Fully Cleared
How POCUS is changing pregnancy care in Kenya
Topical vs Oral JAK Inhibitors in Vitiligo, With Iltefat Hamzavi, MD | HCPLive
Cardiotonic Agents Market to Reach USD 10,337.3 Million by 2034 - Credence Research
Weekly Buzz: RHHBY, NVS, PFE Win FDA Nod; CRBU Scales Back; PCVX, ABBV Report Positive Trial Data
Matchpoint Therapeutics raises $150m Series B
Swiss team explores Telangana’s innovation ecosystem
FRI AM News: WisBusiness: the Podcast with Megan Tanel, Association of Equipment Manufacturers; SEIU says SSM Health nurses have filed new charges against employer
Outlook Therapeutics Names Greg DiPasquale Chief Commercial Officer
Quince Therapeutics Relaunches as IRulya Therapeutics with a Focus on the Clinical Development of LAM-001, Targeting a Key Pathway in Pulmonary Disease
Global CEOs to explore new opportunities in Shanghai - Thailand Business News
To Pick The Right Medical LLM, First Assess Your Readiness
From Apps to Agents: How the 2026 New gTLD Strings Mirror a Changed Internet
australiannews.net: Rockwell Automation, Rockwell Automation, Rockwell Automation (wb 1921 private sector development, wb 1921 private sector development)
Rockwell Automation and Industry Leaders Launch the Digital CMC Consortium to Accelerate Digital Transformation in Pharmaceutical Development
Signals to inspect
Anomalies
Latest 10 in the selected window (up to 10). Detector output, not verified conclusions.
Volume spike: 2 events in window (2.0x baseline of 1.0 expected)
New connection: 271 previously unseen co-actor(s) detected (known network: 497)
Volume spike: 2 events in window (2.0x baseline of 1.0 expected)
New connection: 14 previously unseen co-actor(s) detected (known network: 489)
New connection: 10 previously unseen co-actor(s) detected (known network: 479)
Volume spike: 2 events in window (2.0x baseline of 1.0 expected)
Tone shift: score -8.0 deviates 2.7σ from baseline mean -0.6 (stddev 2.76)
Tone shift: score -8.0 deviates 2.8σ from baseline mean -0.5 (stddev 2.68)
Volume spike: 2 events in window (2.0x baseline of 1.0 expected)
Narrative context
Unresolved threads
Latest 20 at most, across all dates. Stored narratives require human review.
No unresolved threads recorded.
Stored connections
Relationships
Up to 50 records ordered by evidence count, across all dates. Co-mentions indicate association in source material, not affiliation or coordination.
- Novartis→ co mention →White House825 evidence records
- Novartis→ co mention →Jason Thomas Aylward762 evidence records
- Novartis→ co mention →Carl Grillmair762 evidence records
- Novartis→ co mention →William Neil Mccasland759 evidence records
- Monica Jacinto Reza→ co mention →Novartis755 evidence records
- Novartis→ co mention →Frank Werner Maiwald744 evidence records
- Nuno Louriero→ co mention →Novartis738 evidence records
- Propulsion Laboratory→ co mention →Novartis721 evidence records
- Karoline Leavitt→ co mention →Novartis695 evidence records
- Novartis→ co mention →Los Angeles691 evidence records
- Novartis→ co mention →Anthony Chargualaf690 evidence records
- Michael Odell Hicks→ co mention →Novartis689 evidence records
- Novartis→ co mention →Melissa Casterioto683 evidence records
- Alabama Fusion Center→ co mention →Novartis663 evidence records
- Aerojet Rocketdyne→ co mention →Novartis605 evidence records
- Novartis→ co mention →United States Senate572 evidence records
- Novartis→ co mention →Bristol Myers Squibb516 evidence records
- Novartis→ co mention →Novo Nordisk382 evidence records
- Novartis→ co mention →Astrazeneca376 evidence records
- Novartis→ co mention →Eli Lilly331 evidence records
- Novartis→ co mention →Pfizer326 evidence records
- Boehringer Ingelheim→ co mention →Novartis314 evidence records
- Novartis→ co mention →Donald Trump283 evidence records
- Amgen→ co mention →Novartis281 evidence records
- Glasgow Queen Elizabeth University Hospital→ co mention →Novartis231 evidence records
- Sarah Karlin-Smith→ co mention →Novartis231 evidence records
- Drug Enforcement Administration→ co mention →Novartis212 evidence records
- Eboog Johnson→ co mention →Novartis210 evidence records
- Novartis→ co mention →Nasdaq206 evidence records
- Matthew Mcconaughey→ co mention →Novartis180 evidence records
- Sun Pharmaceuticals On→ co mention →Novartis177 evidence records
- Novartis→ co mention →Serena William Crip173 evidence records
- Northwestern University Marching Band→ co mention →Novartis164 evidence records
- Spike Lee→ co mention →Novartis164 evidence records
- Marshawn Lynch→ co mention →Novartis163 evidence records
- Novartis→ co mention →Timothy Calkins162 evidence records
- Glen Lazarus→ co mention →Novartis157 evidence records
- Novartis→ co mention →Oakley Meta Vanguardmodel141 evidence records
- Giles Lomax→ co mention →Novartis133 evidence records
- Jesy Nelsonhas→ co mention →Novartis133 evidence records
- Novartis→ co mention →Neil Gray132 evidence records
- Pearson→ co mention →Novartis132 evidence records
- Novartis→ co mention →Genentech131 evidence records
- Facebook→ co mention →Novartis128 evidence records
- Novartis→ co mention →Monroe Nelson-Foster128 evidence records
- Robert Perry Getty→ co mention →Novartis126 evidence records
- Novartis→ co mention →Danny Lawson126 evidence records
- Novartis→ co mention →Craig Geoghan126 evidence records
- Novartis→ co mention →Health Protection Scotland126 evidence records
- Novartis→ co mention →Tony Graynoth126 evidence records
Ask this desk
Desk analyst
Read-only questions about Novartis's stored record. Answers cite only records retrieved for that turn; a citation chip opens the existing inspection view. Absence of matches is not evidence of inactivity.
Operator sign-in is required. Sign in